Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.

NCT00212368 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT00212368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Lead sponsor
Nobelpharma
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
December 31, 2005
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

wison's disease